Minidose Lidocaine-Fentanyl Spinal Anesthesia in Ambulatory Surgery: Prophylactic Nalbuphine Versus Nalbuphine Plus Droperidol
Authors:
- Bruce Ben-DavidBBBruce Ben-David
- Patrick J. DeMeoPDPatrick J. DeMeo
- Christen LucykCLChristen Lucyk
- David SoloskoDSDavid Solosko
- 1 December 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 95 (6) , 1596-1600
Abstract
Minidose lidocaine-fentanyl spinal anesthesia (SABMLF) is a safe, effective, and efficient anesthetic for ambulatory surgery. Unfortunately, it has a frequent incidence of pruritus and a substantial incidence of nausea and vomiting. Nalbuphine is effective in treating or preventing pruritus after intrathecal or epidural morphine but may or may not have a beneficial effect on nausea and vomiting. Droperidol has demonstrated antiemetic efficacy with neuraxial opiates. In this study, we examined the prophylactic use of nalbuphine alone compared with nalbuphine with droperidol after SABMLF. One-hundred-twenty-four patients having outpatient knee arthroscopy under SABMLF with 20 mg of lidocaine 0.5% and 20 μg of fentanyl were randomized to receive IV at the end of surgery either 4 mg of nalbuphine (Group N) or droperidol 0.625 mg plus nalbuphine 4 mg (Group ND). The incidences of early (before discharge) and late onset nausea were, respectively, 18% versus 5% and 32% versus 13%. The postoperative incidences of pruritus were 61% versus 40%, whereas 19% of patients in Group N compared with 2% of patients in Group ND requested treatment for this. Group ND had lower pain scores and had a longer delay until first use of analgesic. There were no differences in average times to discharge. The only side effect of the medications was an increased drowsiness in Group ND. In conclusion, as prophylactic medication for use in conjunction with SABMLF, the addition of droperidol 0.625 mg to nalbuphine 4 mg was superior to nalbuphine alone. The combination provided for reduced postoperative nausea, pruritus, and pain—benefits that persisted after discharge home. The combination also avoided isolated cases of extreme delay in discharge.Keywords
This publication has 17 references indexed in Scilit:
- Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trialsEuropean Journal of Anaesthesiology, 2001
- Intrathecal Fentanyl-induced Pruritus is More Severe in Combination with Procaine Than with Lidocaine or BupivacaineRegional Anesthesia & Pain Medicine, 2001
- Selective spinal anesthesia for outpatient laparoscopy. I: Characteristics of three hypobaric solutionsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2001
- Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomitingCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
- The Inhibition of Epidural Morphine-induced Pruritus by Epidural DroperidolAnesthesia & Analgesia, 2000
- Droperidol and the Side Effects of Epidural Morphine After Cesarean SectionAnesthesia & Analgesia, 1998
- Intrathecal Fentanyl With Small-Dose Dilute BupivacaineAnesthesia & Analgesia, 1997
- Small-Dose Hypobaric Lidocaine-Fentanyl Spinal Anesthesia for Short Duration Outpatient Laparoscopy. I. A Randomized Comparison with Conventional Dose Hyperbaric LidocaineAnesthesia & Analgesia, 1997
- Reduction of nausea and vomiting from epidural opioids by adding droperidol to the infusate in home-bound patientsJournal of Pain and Symptom Management, 1995
- Potentiation of epidural opioids with epidural droperidolAnaesthesia, 1986